Nkarta (NKTX) Gets a Buy from Leerink Partners
Leerink Partners analyst Daina Graybosch maintained a Buy rating on Nkarta (NKTX – Research Report) yesterday and set a price target of $7.00.
Leerink Partners Remains a Buy on Century Therapeutics (IPSC)
Leerink Partners analyst Daina Graybosch maintained a Buy rating on Century Therapeutics (IPSC – Research Report) yesterday and set a price ...
Yahoo Finance11d
Merck shares tumble as company pauses Gardasil shipments to China
Leerink Partners analyst Daina Graybosch cautioned against too much pessimism, writing “this continued uncertainty is likely ...
Merck projects $64.1B-$65.6B revenue in 2025 amid WINREVAIR growth and GARDASIL rebasing
Rob Davis emphasized Merck's strong performance in 2024, driven by demand for KEYTRUDA, the launch of WINREVAIR, and robust growth in Animal Health. Davis highlighted challenges in GARDASIL sales in ...
Barchart on MSN11d
What Are Wall Street Analysts’ Target Price for Merck Stock?
Rahway, New Jersey-based Merck & Co., Inc. (MRK) functions as a healthcare company. Valued at $252.4 billion by market cap, ...
Nasdaq18d
Forecasting The Future: 12 Analyst Projections For Merck & Co
Across the recent three months, 12 analysts have shared their insights on Merck & Co (NYSE:MRK), expressing a variety of opinions spanning from bullish to bearish. In the table below, you'll find ...
The Garden Island6y
New wheels for ‘Direct Release’
PUHI — Kauai Humane Society has a new van for the Direct Release Program thanks to Howard Appel and David Cohen, owners of Destinations in Paradise.